Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers

被引:136
|
作者
Caron, C. [1 ]
Lestrat, C. [1 ]
Marsal, S. [1 ]
Escoffier, E. [1 ]
Curtet, S. [1 ]
Virolle, V. [2 ,3 ]
Barbry, P. [2 ,3 ]
Debernardi, A. [1 ]
Brambilla, C. [1 ]
Brambilla, E. [1 ]
Rousseaux, S. [1 ]
Khochbin, S. [1 ]
机构
[1] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, Grenoble, France
[2] CNRS, Sophia Antipolis, France
[3] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France
关键词
H4; K5ac; proteasome; chromatin; histone; epigenetics; GENE-EXPRESSION; HISTONE CODE; PROTEIN; BOUNDARY; COACTIVATOR; ATPASE; ROLES; ANCCA;
D O I
10.1038/onc.2010.259
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer cells frequently express genes normally active in male germ cells. ATAD2 is one of them encoding a conserved factor harbouring an AAA type ATPase domain and a bromodomain. We show here that ATAD2 is highly expressed in testis as well as in many cancers of different origins and that its high expression is a strong predictor of rapid mortality in lung and breast cancers. These observations suggest that ATAD2 acts on upstream and basic cellular processes to enhance oncogenesis in a variety of unrelated cell types. Accordingly, our functional studies show that ATAD2 controls chromatin dynamics, genome transcriptional activities and apoptotic cell response. We could also highlight some of the important intrinsic properties of its two regulatory domains, including a functional cross-talk between the AAA ATPase domain and the bromodomain. Altogether, these data indicate that ATAD2 overexpression in somatic cells, by acting on basic properties of chromatin, may contribute to malignant transformation. Oncogene (2010) 29, 5171-5181; doi:10.1038/onc.2010.259; published online 28 June 2010
引用
收藏
页码:5171 / 5181
页数:11
相关论文
共 43 条
  • [1] Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers
    C Caron
    C Lestrat
    S Marsal
    E Escoffier
    S Curtet
    V Virolle
    P Barbry
    A Debernardi
    C Brambilla
    E Brambilla
    S Rousseaux
    S Khochbin
    [J]. Oncogene, 2010, 29 : 5171 - 5181
  • [2] ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
    Luo, Yang
    Ye, Guang-Yao
    Qin, Shao-Lan
    Yu, Min-Hao
    Mu, Yi-Fei
    Zhong, Ming
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [3] Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma
    Baba, Tetsuro
    Shiota, Hironobu
    Kuroda, Koji
    Shigematsu, Yoshiki
    Ichiki, Yoshinobu
    Uramoto, Hidetaka
    Hanagiri, Takeshi
    Tanaka, Fumihiro
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (04) : 759 - 764
  • [4] ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2
    Kalashnikova, Ekaterina V.
    Revenko, Alexey S.
    Gemo, Abigael T.
    Andrews, Nicolas P.
    Tepper, Clifford G.
    Zou, June X.
    Cardiff, Robert D.
    Borowsky, Alexander D.
    Chen, Hong-Wu
    [J]. CANCER RESEARCH, 2010, 70 (22) : 9402 - 9412
  • [5] High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer
    Ruotsalainen, T
    Joensuu, H
    Mattson, K
    Salven, P
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1492 - 1495
  • [6] Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
    Kong, Peng-Zhou
    Li, Guang-Ming
    Tian, Yin
    Song, Bin
    Shi, RuYi
    [J]. ONCOTARGET, 2016, 7 (34) : 55601 - 55610
  • [7] SOX2: profiling a new group of breast cancer patients with poor prognosis
    Pradel, Leon P.
    Hinterseer, Elisabeth
    Bastelberger, Stephan
    Beil, Jane
    Reitsamer, Roland
    Dietze, Otto
    Hauser-Kronberger, Cornelia
    [J]. CANCER RESEARCH, 2010, 70
  • [8] SOX2: profiling a new group of breast cancer patients with poor prognosis
    Pradel, Leon P.
    Hinterseer, Elisabeth
    Bastelberger, Stephan
    Beil, Jane
    Reitsamer, Roland
    Dietze, Otto
    Hauser-Kronberger, Cornelia
    [J]. CANCER RESEARCH, 2010, 70
  • [9] Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor
    Fatma El Zahraa A. Mohamed
    Ali Omar Abdelaziz
    Ahmed Hussein Kasem
    Tarek Ellethy
    Mariana F. Gayyed
    [J]. Scientific Reports, 11
  • [10] Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor
    Mohamed, Fatma El Zahraa A.
    Abdelaziz, Ali Omar
    Kasem, Ahmed Hussein
    Ellethy, Tarek
    Gayyed, Mariana F.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)